Stoke Therapeutics, Inc.

Legal & General Group Plc STOK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/9/2026

Shares

36,366

Value ($000)

1,154

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/9/2026	1,154	0.0%	36,366	12/31/2025
2025 Q3	11/13/2025	888	0.0%	37,783	9/30/2025
2025 Q2	8/12/2025	353	0.0%	31,077	6/30/2025
2025 Q1	5/15/2025	235	0.0%	35,347	3/31/2025
2024 Q4	2/13/2025	390	0.0%	35,347	12/31/2024
2024 Q3	2/28/2025	415	0.0%	33,807	9/30/2024
2024 Q2	5/29/2025	443	0.0%	32,790	6/30/2024
2024 Q1	5/29/2025	31	0.0%	2,278	3/31/2024
2023 Q4	5/29/2025	16	0.0%	3,129	12/31/2023
2023 Q3	11/14/2023	43	0.0%	10,934	9/30/2023
2023 Q2	8/14/2023	161	0.0%	15,192	6/30/2023
2023 Q1	5/15/2023	27	0.0%	3,221	3/31/2023
2022 Q4	2/14/2023	58	0.0%	6,298	12/31/2022
2022 Q3	11/14/2022	81	0.0%	6,298	9/30/2022
2022 Q2	8/22/2022	69	0.0%	5,242	6/30/2022
2022 Q1	5/16/2022	111	0.0%	5,281	3/31/2022
2021 Q4	2/14/2022	127	0.0%	5,281	12/31/2021
2021 Q3	11/15/2021	134	0.0%	5,252	9/30/2021
2021 Q2	8/12/2021	92	0.0%	2,720	6/30/2021
2021 Q1	5/17/2021	78	0.0%	2,005	3/31/2021
2020 Q4	2/12/2021	110	0.0%	1,785	12/31/2020
2020 Q3	11/13/2020	79	0.0%	2,340	9/30/2020
2020 Q2	8/14/2020	49	0.0%	2,059	6/30/2020
2020 Q1	5/14/2020	60	0.0%	2,618	3/31/2020
2019 Q4	2/13/2020	51	0.0%	1,802	12/31/2019